Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia: Part II. In vitro studies

Leukemia Research

Volumn 28, Issue 11, 2004, Pages 1137-1143

  Wright, Daniel G ^a   Boosalis, Michael ^a   Malek, Karim ^a   Waraska, Kristin ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

acute myelogenous leukemia; AML; Chemotherapy sensitivity; chronic myelogenous leukemia; chronic myelogenous leukemia in blast crisis; CML; CML blast crisis; CML BC; IMPDH; inosine monophosphate dehydrogenase; Ph' chromosome; philadelphia chromosome

Indexed keywords

BCR ABL PROTEIN; GUANOSINE; INOSINE PHOSPHATE; OXIDOREDUCTASE; TIAZOFURIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; ENZYME REGULATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS;

ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMP DEHYDROGENASE; K562 CELLS; RIBAVIRIN; RNA, MESSENGER;

EID: 4544343606     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.03.004     Document Type: Article

References (26)

1. Crabtree G.W., Henderson J.F. Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro. Cancer Res. 31:1971;985-991
2. Jackson R.C., Morris H.P., Weber G. Partial purification, properties and regulation of inosine 5′ phosphate dehydrogenase in normal and malignant rat tissues. Biochem. J. 166:1977;1-10
3. Zimmermann A.G., Gu J.J., Laliberte J., Mitchell B.S. Inosine-5′-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T-lymphocyte activation. Prog. Nucl. Acid Res. Mol. Biol. 61:1998;181-209
4. Gu J.J., Kaiser-Rogers K., Rao K., Mitchell B.S. Assignment of the human type I IMP dehydrogenase gene (IMPDH1) to chromosome 7q31.3-q32). Genomics. 24:1994;179-181
5. Zimmermann A.G., Spychala J., Mitchell B.S. Characterization of the human inosine-5′-monophosphate dehydrogenase type II gene. J. Biol. Chem. 270:1995;6808-6814
6. Jackson R.C., Weber G., Morris H.P. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature. 256:1975;331-333
7. Gruber H.E., Jansen I., Willis R.C., Seegmiller J.E. Alterations of inosinate branchpoint enzymes in cultured human lymphoblasts. Biochem. Biophys. Acta. 846:1985;135-144
8. Konno Y., Natsumeda Y., Nagai M., Yamaji Y., Ohno S., Suzuki K., Weber G. Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines. J. Biol. Chem. 266:1991;506-509
9. Collart F.R., Chubb C.B., Mirkin B.L., Huberman E. Increased inosine-5′-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. Cancer Res. 52:1992;5826-5828
10. Nagai M., Natsumeda Y., Weber G. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. Cancer Res. 52:1992;258-261
11. Gharehbaghi K., Burgess G.S., Collart F.R., Litz-Jackson S., Huberman E., Jayaram H.N., Boswell H.S. p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene. Leukemia. 8:1994;1257-1263
12. Dayton J.S., Lindsten T., Thompson C.B., Mitchell B.S. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression. J. Immunol. 152:1994;984-991
13. Glesne D.A., Collart F.R., Huberman E. Regulation of IMP dehydrogenase gene expression by its end products, guanine ribonucleotides. Mol. Cell Biol. 11:1991;5417-5425
14. Escobar-Henriques M., Daignan-Fournier B. Transcriptional regulation of the yeast GMP synthesis pathway by its end products. J. Biol. Chem. 276:2001;1523-1530
15. Lucas D.L., Webster H.K., Wright D.G. Purine metabolism in myeloid precursor cells during maturation: Studies with the HL-60 cell line. J. Clin. Invest. 72:1983;1889-1900
16. Wright D.G. A role for guanine ribonucleotides in the regulation of myeloid cell maturation. Blood. 69:1987;334-338
17. Balzarini J., De Clercq E. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes. Biochem. J. 287:1992;785-790
18. Melamed MR, Mullaney PF, Mendelsohn ML, Flow cytometry and sorting. 3rd ed. New York: Wiley-Liss; 1990.
19. Duan D.-S., Sadee W. Distinct effects of adenine and guanine starvation on DNA synthesis associated with different pool sizes of nucleotide precursors. Cancer Res. 47:1987;4047-4051
20. Linke S.P., Clarkin K.C., DiLeonardo A., Tsou A., Wahl G.M. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:1996;934-947
21. Luskey L.L., Faust J.R., Chin D.J., Brown M.S., Goldstein J.L. Amplification of the gene for 3-hydroxy-3-methylglutaryl ccoenzyme A reductase, but not for the 53-kDa protein, in UT-1 cells. J. Biol. Chem. 258:1983;8462-8469
22. Tricot G.J., Jarayam H.N., Lapis E., Natsumeda Y., Nichols C.R., Kneebone P., Heerema N., Weber G., Hoffman R. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5′-monophosphate dehydrogenase activity. Cancer Res. 49:1989;3696-3701
23. Tricot G., Weber G. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase activity. Anticancer Res. 16:1996;3341-3347
24. Taniki T., Prajda N., Monden Y., Weber G. Synergistic action of taxol and tiazofurin in human ovarian, pancreatic and lung carcinoma cells. Cancer Biochem. Biophys. 13:1993;295-302
25. Yeh Y.A., Olah E., Wendel J.J., Sledge G.W. Jr., Weber G. Synergistic action of taxol with tiazofurin and methotrexate in human breast cancer cells: schedule-dependence. Life Sci. 54:1994;431-435
26. Harrison S.D., O'Dwyer P.J., Trades M.W. Therapeutic synergism of tiazofurin and selected antitumor drugs against sneisitive and resistant P388 leukemia in mice. Cancer Res. 46:1986;3396-3400